68 Results

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. Tallman
    Tallman
  3. Levine
    Levine
  4. Park
    Park
  5. Patel
    Patel
  6. Rampal
    Rampal
  7. Chung
    Chung
  8. Chung
    Chung
  9. Gonen
    Gonen
  10. Stein
    Stein

Groups

  1. Adult Leukemia (68)
  2. Center for Hematologic Malignancies (68)
  3. Department of Medicine (68)
  4. Executive Committee, Center for Hematologic Malignancies (68)
  5. GSK Faculty (68)
  6. Hematologic Malignancies, Division of (68)
  7. Human Oncology and Pathogenesis Program (68)
  8. Tow Center for Developmental Oncology (TCDO) (68)
  9. Biostatistics Service (24)
  10. Epidemiology and Biostatistics (24)
  1. "Omar Abdel-Wahab"
  2. "Martin Tallman"
Formats
  1. Meeting Abstract (34)
  2. Journal Article (32)
  3. Book Section (1)
  4. Review (1)
Groups
  1. Adult Leukemia (68)
  2. Center for Hematologic Malignancies (68)
  3. Department of Medicine (68)
  4. Executive Committee, Center for Hematologic Malignancies (68)
  5. GSK Faculty (68)
  6. Hematologic Malignancies, Division of (68)

More Groups

People
  1. Martin Tallman (68)
  2. Omar Abdel-Wahab (68)
  3. Ross Levine (44)
  4. Jae Park (28)
  5. Jay Patel (20)
  6. Raajit Rampal (15)

More People

Years
  1. 2023 (5)
  2. 2022 (3)
  3. 2021 (3)
  4. 2020 (6)
  5. 2019 (4)
  6. 2018 (3)

More Years

Publications
  1. Blood (36)
  2. Blood Advances (3)
  3. Haematologica (3)
  4. Leukemia (3)
  5. Leukemia Research (3)
  6. British Journal of Haematology (2)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. Nature Publishing Group (5)
  3. Elsevier Ltd (3)
  4. Ferrata Storti Foundation (3)
  5. Massachusetts Medical Society (3)
  6. American Association for Cancer Research (2)

More Publishers

Results (68)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia
    Journal Article

    Park, J. H.; Devlin, S.; Durham, B. H.; Winer, E. S.; Huntington, S.; von Keudell, G.; Vemuri, S.; Shukla, M.; Falco, V.; Cuello, B.; more...
    NEJM Evidence (2023)

    Fulltext@MSK | Save
  • Characteristics and prognostic impact of IDH mutations in AML: A COG, SWOG, and ECOG analysis
    Journal Article

    Zarnegar-Lumley, S.; Alonzo, T. A.; Gerbing, R. B.; Othus, M.; Sun, Z.; Ries, R. E.; Wang, J.; Leonti, A.; Kutny, M. A.; Ostronoff, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Characteristics and prognostic effects of DNMT3A co-mutations
    Meeting Abstract

    Torabi, A.; Alonzo, T. A.; Othus, M.; Gerbing, R. B.; Wang, Y. C.; Ries, R. E.; Radich, J. P.; Appelbaum, F. R.; O'Dwyer, K.; Erba, H. P.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy
    Journal Article

    Handa, S.; Lee, J. O.; Derkach, A.; Stone, R. M.; Saven, A.; Altman, J. K.; Grever, M. R.; Rai, K. R.; Shukla, M.; Vemuri, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
    Journal Article

    Ganzel, C.; Sun, Z.; Baslan, T.; Zhang, Y.; Gönen, M.; Abdel-Wahab, O. I.; Racevskis, J.; Garrett-Bakelman, F.; Lowe, S. W.; Fernandez, H. F.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • First line chemo-free therapy with the BRAF inhibitor vemurafenib combined with obinutuzumab is effective in patients with HCL
    Meeting Abstract

    Park, J. H.; Winer, E. S.; Huntington, S. F.; von Keudell, G.; Vemuri, S.; Shukla, M.; Kinoshita, J. C.; Falco, V.; Gore, S. D.; Stone, R. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL
    Journal Article

    Paietta, E.; Roberts, K. G.; Wang, V.; Gu, Z.; Buck, G. A. N.; Pei, D.; Cheng, C.; Levine, R. L.; Abdel-Wahab, O.; Cheng, Z.; more...
    Blood (2021)

    Fulltext@MSK | Save